Neuphoria Therapeutics Inc. financial statements
Neuphoria Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 1.17M | 10-K |
| Net income | −USD 13.45M | 10-K |
| Cash and equivalents | USD 19.87M | 10-Q |
| Total debt | USD 34.34K | EODHD |
Neuphoria Therapeutics Inc. financials on 6ix · Neuphoria Therapeutics Inc. on 6ix